Cargando…
PPARγ activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFβ signalling
The thiazolidinediones (TZDs) are a class of synthetic antidiabetic drugs exerting its action primarily upon acti-vation of the peroxisome proliferator-activated receptor-γ (PPARγ). Given the widespread incidence of diabetes type II and lifelong exposure of these patients to TZDs, there is a possibi...
Autores principales: | Jarrar, Mohammed H, Baranova, Ancha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401221/ https://www.ncbi.nlm.nih.gov/pubmed/17367502 http://dx.doi.org/10.1111/j.1582-4934.2007.00003.x |
Ejemplares similares
-
What Is the Future of Thiazolidinediones (TZDs) After Market Introduction of Inhaled Insulin?
por: Curtiss, Frederic R.
Publicado: (2006) -
Thiazolidinediones (TZDs) enhance insulin secretory response via GPR40 and adenylate cyclase (AC)
por: Hwang, Mina, et al.
Publicado: (2021) -
Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
por: Wei, Wei, et al.
Publicado: (2011) -
Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
por: Chiu, Melody, et al.
Publicado: (2017) -
PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors
por: Lichtor, Terry, et al.
Publicado: (2008)